Financials
- Market Capitalization 209.83 M
- Employee 235
- Founded 1983
- CEO N/A
- Website www.anika.com
- Headquarter Delaware, United States
- FIGI BBG000BBKZD8
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3377 | TKNO Alpha Teknova, Inc. - Common Stock | 5.41 USD | +0.93% | -2.35% | +28.81% | +21.30% | 290.05 M USD | ||
| 3454 | SIGA SIGA Technologies Inc. - Common Stock | 3.61 USD | +0.56% | -4.50% | -16.82% | -57.53% | 258.92 M USD | ||
| 3666 | DERM Journey Medical Corporation - Common Stock | 6.86 USD | -0.72% | -5.90% | +7.69% | -7.30% | 188.89 M USD | ||
| 3717 | LFCR Lifecore Biomedical, Inc. - Common Stock | 4.63 USD | -2.53% | -7.95% | -18.20% | -43.26% | 173.67 M USD |
Frequently asked questions about Anika Therapeutics Inc. - Common Stock
What is the Anika Therapeutics Inc. - Common Stock stock price today?
The current price of Anika Therapeutics Inc. - Common Stock (ANIK) is 15.77. Over the past 24 hours, the stock has changed by +1.09%. Follow the ANIK chart for real-time price dynamics.
What is the stock ticker of Anika Therapeutics Inc. - Common Stock?
Anika Therapeutics Inc. - Common Stock trades under the ticker ANIK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Anika Therapeutics Inc. - Common Stock stock going up?
ANIK has changed by -2.59% over the last week, +7.13% over the last month, and +55.52% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Anika Therapeutics Inc. - Common Stock net income for the last quarter?
Anika Therapeutics Inc. - Common Stock reported net income of -5.06 M for the last quarter. The previous quarter showed 292 K, which means net income changed by -1831.51%.
How many employees does Anika Therapeutics Inc. - Common Stock have?
As of the latest available data, Anika Therapeutics Inc. - Common Stock has 235 employees. Workforce size can provide additional context about the company's scale and operations.
What is Anika Therapeutics Inc. - Common Stock EBITDA?
Anika Therapeutics Inc. - Common Stock EBITDA is 6.53 M, and its EBITDA margin is 22.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Anika Therapeutics Inc. - Common Stock stock?
You can buy Anika Therapeutics Inc. - Common Stock (ANIK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Anika Therapeutics Inc. - Common Stock stock?
Investing in Anika Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANIK chart and related analysis on metatrader.com as part of your research.